The Development of Hyaluronan as a Drug Transporter and Excipient for Chemotherapeutic Drugs

E-ISSN： 1873-4316|9|4|253-260

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.9, Iss.4, 2008-08, pp. : 253-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of: "Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems"

By Brittain Harry G.

Pharmaceutical Development and Technology, Vol. 12, Iss. 1, 2007-01 ,pp. : 109-110

Informa Healthcare

Access to resources Recommend Favorite

Drug-excipient interactions and their affect on absorption

By Jackson K. Young D. Pant S.

Pharmaceutical Science & Technology Today, Vol. 3, Iss. 10, 2000-10 ,pp. : 336-345

Elsevier

Access to resources Recommend Favorite

Utilizing quantitative certificate of analysis data to assess the amount of excipient lot-to-lot variability sampled during drug product development

By Kushner Joseph

Pharmaceutical Development and Technology, Vol. 18, Iss. 2, 2013-04 ,pp. : 333-342

Informa Healthcare

Access to resources Recommend Favorite

Beta-casein Nanoparticles as an Oral Delivery System for Chemotherapeutic Drugs: Impact of Drug Structure and Properties on Co-assembly

By Shapira Alina Assaraf Yehuda Epstein Dikla Livney Yoav

Pharmaceutical Research, Vol. 27, Iss. 10, 2010-10 ,pp. : 2175-2186

Springer Publishing Company

Access to resources Recommend Favorite

Drug Interactions Between Anti‐Epileptics and Chemotherapeutic Drugs: Value of a Pre‐Treatment Pharmaceutical Review

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 41, Iss. 1, 2011-03 ,pp. : 42-44

John Wiley & Sons Inc

Access to resources Recommend Favorite